Quality of life in patients with esophageal cancer receiving definitive chemoradiotherapy or esophagectomy

Lv,Yajuan; Zhang,Jiandong; Qiao,Lili

doi:10.3892/mco.2014.313

Quality of life in patients with esophageal cancer receiving definitive chemoradiotherapy or esophagectomy

Authors:
- Yajuan Lv
- Jiandong Zhang
- Lili Qiao
View Affiliations

Affiliations: Department of Radiation, Qianfoshan Hospital, Jinan, Shandong 250014, P.R. China
Published online on: June 12, 2014 https://doi.org/10.3892/mco.2014.313
Pages: 870-874

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to assess the variation in the quality of life (QOL) of patients with esophageal cancer receiving definitive chemoradiotherapy or esophagectomy, and to explore the main factors that affects QOL. A total of 102 patients with esophageal cancer receiving definitive chemoradiotherapy or esophagectomy were assessed using a QOL questionnaire, and a numeric score was calculated in each conceptual area and compared with reference data by a statistical method. With regards to the impacts on the QOL, the chemoradiotherapy had less of an impact compared with esophagectomy. The QOL declined following the two treatments, but was restored in a specific period of time. In the present study, the main factors that affected the QOL of patients included physical function, fatigue and pain. Definitive chemoradiotherapy is therefore superior to esophagectomy with regard to its effect on the QOL. The two treatments had an effect on the QOL of patients, but this effect was temporary and was resumed after a period of time.

View Figures

View References

1	Rice TW, Adelstein DJ, Chidel MA, et al: Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg. 126:1590–1596. 2003. View Article : Google Scholar
2	Fayers P and Bottomley A; EORTC Quality of Life Group; Quality of Life Unit. Quality of life research within the EORTC-the EORTC QLQ-C30. Eur J Cancer. 38(Suppl 4): 125–133. 2002. View Article : Google Scholar : PubMed/NCBI
3	Olschewski M, Schulgen G, Schumacher M and Altman DG: Quality of life assessment in clinical cancer research. Br J Cancer. 70:1–5. 1994. View Article : Google Scholar
4	Sinqer S, Hofmeister D, Spieqel K and Boehm A: Current developments in measuring quality of life with instruments of the European organisation for research and treatment of cancer (EORTC). Laryngorhinootologie. 90:591–594. 2011.(In German).
5	Blazeby JM, Conroy T, Hammerlid E, et al; European Organisation for Research and Treatment of Cancer Gastrointestinal and Quality of Life Groups. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer. 39:1384–1394. 2003. View Article : Google Scholar : PubMed/NCBI
6	Chiu PW, Chan AC, Leung SF, et al: Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg. 9:794–802. 2005. View Article : Google Scholar
7	Ando N, Ozawa S, Kitagawa Y, et al: Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg. 232:225–232. 2000.PubMed/NCBI
8	Wilson KS and Lim JT: Primary chemo-radiotherapy and selective oesophagectomy for oesophageal cancer: goal of cure with organ preservation. Radiother Oncol. 54:129–134. 2000. View Article : Google Scholar : PubMed/NCBI
9	Rice TW, Adelstein DJ, Chidel MA, et al: Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg. 126:1590–1596. 2003. View Article : Google Scholar : PubMed/NCBI
10	Courrech Staal EF, van Sandick JW, van Tinteren H, Cats A and Aaronson NK: Health-related quality of life in long-term esophageal cancer surviors after potentially curative treatment. J Thorac Cardiovasc Surg. 140:777–782. 2010.
11	Yap CJ, Malhotra HK and Yang GY: Intensity modulated radiation therapy in the treatment of esophageal cancer. Thorac Cancer. 1:62–69. 2010. View Article : Google Scholar
12	Lagergren P, Avery KN, Hughes, et al: Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer. 110:686–693. 2007. View Article : Google Scholar : PubMed/NCBI
13	Avery KN, Metcalfe C, Barham CP, et al: Quality of life during potentially curative treatment for locally advanced oesophageal cancer. Br J Surg. 94:1369–1376. 2007. View Article : Google Scholar : PubMed/NCBI
14	de Boer AG, van Lanschot JJ, van Sandick JW, et al: Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol. 22:4202–4208. 2004.PubMed/NCBI
15	Dancey J, Zee B, Osoba D, et al: Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. Qual Life Res. 6:151–158. 1997. View Article : Google Scholar
16	Blazeby JM, Brookes ST and Alderson D: Prognostic value of quality of life scores in patients with oesophageal cancer. Br J Surg. 87:362–373. 2000. View Article : Google Scholar : PubMed/NCBI
17	Fang FM, Tsai WL, Chiu HC, et al: Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys. 58:1394–1404. 2004. View Article : Google Scholar : PubMed/NCBI
18	Johnson JR and Temple R: Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treat Rep. 69:1155–1159. 1985.PubMed/NCBI
19	Homs MY, Essink-Bot ML, Borsboom GJ, et al; Dutch SIREC Study Group. Quality of life after palliative treatment for oesophageal carcinoma - a prospective comparison between stent placement and single dose brachytherapy. Eur J Cancer. 40:1862–1871. 2004. View Article : Google Scholar
20	de Boer AG, van Lanschot JJ, van Sandick JW, et al: Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol. 22:4202–4208. 2004.PubMed/NCBI
21	Roila F and Cortesi E: Quality of life as a primary end point in oncology. Ann Oncol. 112(Suppl 3): S3–S6. 2001. View Article : Google Scholar : PubMed/NCBI
22	Winell J and Roth AJ: Depression in cancer patients. Oncology (Williston Park). 18:1554–1562. 2004.
23	Pasquini M and Biondi M: Depression in cancer patients: a critical review. Clin Pract Epidemol Ment Health. 3:22007. View Article : Google Scholar : PubMed/NCBI